GB Sciences, Inc.
(Other OTC/NBB : GBLX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.11%64.431.0%$560.69m
AMGNAmgen, Inc. 1.66%228.571.3%$486.38m
BIIBBiogen, Inc. -0.07%281.751.4%$395.61m
ILMNIllumina, Inc. 0.23%315.003.5%$328.49m
VRTXVertex Pharmaceuticals, Inc. 0.40%232.901.9%$277.92m
REGNRegeneron Pharmaceuticals, Inc. -0.77%341.422.6%$248.80m
EXASEXACT Sciences Corp. 0.79%91.4324.0%$230.16m
ALXNAlexion Pharmaceuticals, Inc. 1.37%108.442.0%$181.03m
AAgilent Technologies, Inc. 0.91%87.971.6%$138.21m
INCYIncyte Corp. -1.57%75.262.5%$127.62m
SRPTSarepta Therapeutics, Inc. 2.57%120.9714.6%$118.95m
BMRNBioMarin Pharmaceutical, Inc. 0.88%86.654.3%$113.57m
SGENSeattle Genetics, Inc. -0.79%112.046.1%$106.98m
DERMDermira, Inc. -0.27%18.753.8%$85.78m
BLUEbluebird bio, Inc. -0.86%83.2414.2%$83.67m

Company Profile

GB Sciences, Inc. engages in the biopharmaceutical research and development of cannabis plant into medicines, therapies, and treatments. It intends to identify and develop cannabis-based therapies that target specific diseases or medical conditions. The company was founded on April 4, 2001 and is headquartered in Las Vegas, NV.